As a pharmaceutical company seeks to guide a new product from concept to commercial success, it must effectively harness an important tool: the scholarly research paper. A clear understanding of the roles an article can play and the challenges of maximizing its effectiveness are valuable knowledge for any pharma executive. Let’s first review the multiple roles a paper can play and then assess the challenges.
During the preclinical study phase, your company’s researchers will be navigating through the millions of articles that exist in support of the scientific process. After preclinical work, clinical trials are conducted and the publication-planning process accelerates, culminating in scholarly articles that will be submitted to peer-reviewed academic journals. Once published, they become a major part of your investigational new drug application (INDA) submitted to the FDA. If the FDA approves your product, the articles take on a new role as your marketing efforts begin. As witnessed by the growing importance of evidence-based promotions, there is no greater weapon in your sales representatives’ arsenal than research studies that can be effectively presented along with prescribing guidelines to the healthcare professionals (HCPs) with whom they meet. Being able to back up one’s claims for a medication with science — in addition to the promotional materials prepared by your marketing firm — is not only a good idea; it has become the chief method by which you can distinguish yourself from rival companies with competing drugs. It has also become one of the few ethical methods remaining to communicate with HCPs in light of the highly restricted code of interactions adopted within recent years.
To find more information please click here: Life Science Leader: Scientific Articles: The Engine Inside Pharma
No comments:
Post a Comment